Document:

Restated Stock Ownership Program, effective as of January 1, 2010

 Exhibit 10.31 
  

					
		 	 Jones Lang LaSalle Incorporated
  
 Stock Ownership Program
  
 Effective as of January 1, 2010
	 	

 Jones Lang LaSalle Incorporated (the “Company”) sponsors a series of compensation and benefit
programs to assist Directors meet their personal financial goals. In an effort to help increase awareness and understanding of its Stock Ownership Program (“SOP”), the Company has created this summary. 
 PROGRAM OBJECTIVES 
 The SOP
establishes desirable ownership guidelines for the Company’s executive officers as well as International and Regional Directors in order to: 
  

	 	•	 	 Align a portion of the compensation of those employees who are most responsible for the results of the Company with the interests of shareholders.

  

	 	•	 	 Reward people who make long-term contributions to the Company and encourage retention through long-term wealth building incentives.

  

	 	•	 	 Reinforce the “one firm” mindset by encouraging employee ownership across business units and regions. 

 The following desirable minimum stock ownership guidelines have been established: 
 Table 1: Stock Ownership Guidelines 
  

			
	 Director Level
	 	 Beneficial Ownership Guideline (*)

	Chief Executive Officer	 	 Four times annual base salary
 or 50,000 shares

	Members of Global Executive Committee	 	 Four times annual base salary
 or 40,000 shares

	International Director	 	 Four times annual base salary
 or 10,000 shares

	Regional Director	 	 Two times annual base salary
 or 5,000 shares

 (*) In each case, the lesser of
the base salary multiple or share requirement. 
 The Company evaluates Directors’ positions relative to these guidelines each year,
using the current annualized base salary, the fair market value of Company stock and the Director’s beneficial ownership of Company stock. 
 Directors may satisfy their ownership guideline through shares owned directly, shares owned by a spouse or a trust, the potential gain from outstanding stock options, and unvested or deferred restricted stock units. Although there is no
specific period of time in which covered employees should achieve the ownership guidelines, Directors are expected to make continuous progress toward the target and to ideally maintain the applicable level once it has been achieved. 
 PARTICIPATION REQUIREMENTS 
 To help
Directors reach these ownership objectives, International and Regional Directors are separately paid a portion of their incentive compensation (“Total Award”) as a discretionary Stock Bonus (rather than as a discretionary Cash Bonus,
commission or 

 other variable incentive), awarded in the form of restricted stock units (“SOP Shares”) under the
Company’s Stock Award and Incentive Plan (the “Plan”). In addition, effective for the 2010 performance period (for Total Awards payable in 2011) the Company increases the value of SOP Shares by 20% when awarded (generally referred to
as the “SOP Uplift”). Members of the Global Executive Committee are not eligible for the Company-paid SOP Uplift. The number of SOP Shares to be awarded as a Stock Bonus is based upon the following criteria and the schedule provided in
Table 2 below. 
 (a) The employee’s Director level status as of January 1 for the year to which the Total Award
relates (or date of hire if hired during the year). Employees who may be promoted to Regional Director during the year do not participate in the SOP for the remaining portion of the year they were promoted. Similarly, Regional Directors promoted to
International Director continue to participate at the Regional Director level for the remaining portion of the year they were promoted and begin new participation at the International Director level for the following year. 
 (b) The closing price per share of Company common stock as of the first trading day in January of the year following the year in which the
Total Award relates. For example, the number of SOP Shares awarded in January, 2010 as part of the 2009 Stock Bonus was determined based on the closing price of the Company’s common stock as of January 4, 2010, or $61.53. With the 20%
“SOP Uplift” described above, the $61.53 closing price resulted in a discounted share price of approximately $51 when calculating the number of SOP Shares employees’ received in lieu of a discretionary Cash Bonus. 
 (c) The currency exchange rate in effect as of the last trading day in December of the year to which the Total Award relates, as determined
by the Company. 
 Table 2: Cash Bonus and Stock Bonus Levels 
  

					
	 Director Level
	 	 Percentage of Total Award
 Paid as Cash Bonus
	 	 Percentage of Total Award
 Separately Paid as SOP Shares

	 International Director
	 	80%	 	20%
	 Regional Director
	 	85%	 	15%

 For example, if a Regional
Director received a Total Award of $60,000 (approximately €41,850), the Director would receive a Cash Bonus of $51,000 (85% of $60,000) and a Stock Bonus of $9,000 (15% of $60,000). The number of SOP Shares to be awarded, assuming a closing
price of $61.53 per share and an exchange rate of €1.00 to $1.44, is shown below in each of the two examples: 
 Example 1: Total
Award paid in U.S. dollars: 
  

			
	SOP Shares	  	= Stock Bonus ($9,000) plus 20% Company SOP Uplift ($1,800)
		  	= $10,800 divided by $61.53 (closing price)
		  	= 176 shares

 Example 2: Total Award paid in
Euros: 
  

			
	SOP Shares	  	= Stock Bonus (€ 6,278) plus 20% Company SOP Uplift (€1,255)
		  	= € 7,533 times $1.44 (exchange rate) divided by $61.53 (closing price)
		  	= 176 shares

 Minimum Participation Levels 

 Participation in the SOP requires that the minimum value of Stock Bonus to be paid as SOP Shares be no less than US $2,000 (before SOP Uplift
is applied). For example, typically a Regional Director would need to be eligible to receive a Total Award greater than US $13,300 to qualify for SOP Shares. For those that do not have Total Awards that meet the minimum Stock Bonus threshold, no SOP
Shares are awarded and the employee receives his/her Total Award paid in cash, with no 20% premium. 

 Maximum Participation Levels 
 The maximum amount of Stock Bonus to be paid as SOP Shares will be US $150,000 (before SOP Uplift is applied). For example, an International Director receiving a Total Award greater than US $750,000 would
have no more than US $150,000 paid as a Stock Bonus. Any Total Award not paid as SOP Shares under this provision would be paid as a Cash Bonus. 
 Voluntary Election to Not Participate 
 For treatment of 2010 Total Awards, International and Regional Directors may (but
are not required to) opt out of receiving SOP Shares if they hold shares in the Company whose value exceeds the minimum stock ownership guidelines described in Table 1 of this booklet. This notification must be communicated in writing to the
Regional HR Director and have supporting documentation showing that the minimum required level of individual stock ownership has been achieved. 
 If such an election is made, these individuals receive their Total Award in cash at the same time all other annual bonuses are paid, with no 20% premium. This election is not available in certain countries where the availability of the
election would result in immediate taxation of SOP Shares. The election will be specific to treatment of 2010 Total Award and will not automatically roll forward to determine SOP treatment of any future Total Award. 
 Voluntary Election to Reduce SOP Shares 
 In order to balance the amount of stock and cash an employee may receive for their Total Award, Directors can voluntarily reduce, by five (5) percentage points, the amount of the Total Award he or she would receive as SOP Shares. If
this election results in a Stock Bonus of less than US$2,000 (before the uplift is applied), the Total Award is paid in cash. If no notice to reduce SOP is received within the required deadlines, the amount of SOP Shares to be awarded defaults to
the standard SOP schedule shown in Table 2 above. The election will be specific to treatment of 2010 Total Award and will not automatically roll forward to determine SOP treatment of any future Total Award. 
 VESTING OF SOP SHARES 
 Any SOP Shares that a Director receives will be awarded as of the immediately preceding January 1st 
and will vest according to the following schedule, subject to the Director continuing to be employed by the Company as of each Vesting Date, and the terms of the specific agreement which
memorializes the terms of the award: 
  

	 	•	 	 50% of SOP Shares vest on the 1st July that is 18 months after the award date; and

  

	 	•	 	 50% of SOP Shares vest on the 1st July that is 30 months after the award date.

 For example, SOP Shares were awarded on January 1, 2010 as part of the Total Award for 2009 that were
communicated in the first quarter of 2010. Half of these SOP Shares will vest on July 1, 2011 and the other half will vest on July 1, 2012. 
 DIVIDEND EQUIVALENTS; NO VOTING RIGHTS 
 Since a cash dividend was first announced in August 2005, employees who were
awarded SOP Shares received an additional benefit in the form of a semi-annual dividend equivalent payment. The Board of Directors may, in its discretion from time to time, continue to award dividend equivalents to employees who were awarded SOP
Shares. Dividend equivalents are the rights to receive cash, common stock, or other property equal in value to the amount of dividends paid with respect to the Company’s common stock. SOP Shares do not otherwise have a legal right to receive
dividends until vested. SOP Shares do not have voting rights until they have vested. 

 FORFEITURE 
 All SOP Shares are subject to the terms and conditions outlined in a award agreement and to the terms and conditions contained in the Plan. By receiving and accepting a discretionary award of SOP Shares,
all Directors accept all terms and conditions. For example, these conditions apply for terminated employees: 
 - Voluntary
Resignation or Termination for Cause – results in the immediate forfeiture of SOP Shares that are not yet vested.  
 - Termination by Reason of Retirement – outstanding awards will continue to vest according to their standard vesting schedule and shares of stock shall be issued in accordance with the standard vesting schedule. For purposes of
SOP Shares, Retirement means age 65 or where any combination of age and years of service equals 65, as long as the employee is at least 55 years old. If a specific local legal requirement requires this employee stock program to comply with a
different definition, the local laws would prevail. In either case, the retired employee will be required to sign a non-solicitation and non-compete agreement at the time of retirement; 
 - Termination by Reason of Death, Total and Permanent Disability, – the award will continue to vest according to the standard
vesting schedule; 
 - SOP Shares will not be forfeited, and will continue to vest on their original schedules in the event an
employee is involuntarily terminated due to position elimination. 
 TAX CONSIDERATIONS 
 All Cash Bonuses are subject to normal taxes and social charges, as required by local tax laws. The tax consequences associated with the award and payment of
a Stock Bonus as SOP Shares, as well as any anticipated dividend equivalent payments and eventual sale of stock, are always subject to individual income tax circumstances at the time of award, vesting and sale. In general, the Company anticipates
that there will be no income tax obligations for an employee at the time SOP Shares are awarded. Subject to the tax laws in the countries that apply to different employees, the vesting of SOP Shares will create a tax reporting event based on the
number of shares vesting and the closing price of the stock the day before the vesting date. Individuals should seek advice of their personal tax advisor to obtain specific information concerning the tax consequences associated with participation in
SOP. 
 RIGHTS AS A STOCKHOLDER 
 The holder of an award will have no rights as a shareholder with respect to any shares covered by the award except as expressly contained or provided for in the award agreement or the Plan until the vesting of the award. 
  

	
	  
 Disclaimer
  
 This summary of our Stock
Ownership Program is subject to the terms and conditions of the Plan and each underlying award agreement issued thereunder. In the event of a conflict, the terms of the Plan or the underlying award agreement shall prevail. Any terms not otherwise
defined in this summary shall have the meaning provided for in the Plan or the award agreement issued thereunder.Amd. No. 2 to the Amended and Restated Collaborative Research Agreement

 EXHIBIT 10.3C 
 [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions. 
 AMENDMENT NO. 2 TO THE AMENDED AND RESTATED 
 COLLABORATIVE RESEARCH AGREEMENT 
 THIS AMENDMENT NO. 2 TO THE AMENDED AND RESTATED COLLABORATIVE RESEARCH
AGREEMENT, together with exhibits and schedules attached hereto, (the “Second Amendment”) is entered into and effective as of February 23, 2010 (the “Second Amendment Date”) by
and between Equilon Enterprises LLC dba Shell Oil Products US, a Delaware limited liability company, having a place of business at 910 Louisiana Street, Houston, Texas 77002, (“Shell”) and Codexis, Inc., a Delaware
corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063 (“Codexis”). Shell and Codexis may each be referred to herein individually as a “Party” or, collectively, as the
“Parties.” 
 WHEREAS, Shell and Codexis entered into a certain Amended and Restated
Collaborative Research Agreement, effective as of November 1, 2006, and amended such agreement as of March 4, 2009, (collectively, the “Research Agreement”) pursuant to which the Parties have collaborated to develop
certain new biocatalytic processes for use in the conversion of biomass to fuels and/or fuel additives and/or lubricants; and 
 WHEREAS, the Parties desire to amend certain of the terms of the Research Agreement to revise and clarify such certain terms, all on the terms and conditions set forth below. 
 NOW, THEREFORE, in consideration of the promises and undertakings set forth herein, the
Parties hereby agree as follows: 
  

	1.	ARTICLE 1, DEFINITIONS, shall be amended as follows: 

 (a) Section 1.12 is hereby deleted and replaced in its entirety by the following: 
 1.12 “FTE” means the efforts of one or more employees of Codexis (hereinafter a “Codexis FTE”) or an Affiliate of Codexis located in Hungary,
(“CLH”) (hereinafter a “CLH FTE”) equivalent to the efforts of one full time employee (i.e., an employee that works at least one thousand seven hundred sixty (1760) hours per year). 
  

	2.	ARTICLE 2, PROGRAM ACTIVITIES, shall be amended as follows: 

 (a) Section 2.4(a)(i)(1) is hereby deleted and replaced in its entirety by the following: 
 (1) summary written reports within thirty (30) days after the end of each calendar quarter, describing such Party’s work and progress, if any, under the Research Plans; 
 (b) Section 2.4(a)(i)(2) is hereby deleted and replaced in its entirety by the following: 
 (2) annual executive summaries within thirty (30) days after the end of each calendar year for each Research Plan for
which work was performed during the relevant calendar year; 

 (c) Section 2.4(b) is hereby deleted and replaced in its entirety by the following:

 (b) Materials. During the Term, Codexis, and/or an Affiliate of Codexis, and Shell, and/or an Affiliate
of Shell, shall, as a matter of course as described in the Research Plans, or upon each other’s written or oral request, furnish to each other, and/or to each other’s Affiliate(s), samples of biochemical, biological or synthetic chemical
materials which are part of Shell Technology, Codexis Technology or Program Technology which are necessary for each Party to carry out its responsibilities under the Research Plans. As between the Parties and their Affiliates, as applicable, such
materials will be governed by and subject to the terms and conditions set forth in the Research Agreement. Each Party confirms that, in the event (i) a Party provides materials to an Affiliate of the other Party and/or (ii) an Affiliate of
a Party provides materials to an Affiliate of the other Party, prior to any provision of materials, the Party whose Affiliate is to receive such materials has advised such Affiliate of the restrictions contained in the Research Agreement relating to
the provision of such materials by a Party and/or its Affiliate(s) to the other Party and/or its Affiliate(s), including restrictions on use, transfer, disclosure, and preparation of derivatives, and each Affiliate of a Party to receive such
materials has agreed to abide by such restrictions prior to receipt of any such materials. 
 (d) Section 2.6(c) is hereby
deleted and replaced in its entirety by the following: 
 (c) Reduction in FTEs. 
 (i) During the period beginning on May 1, 2009 and ending on November 1, 2010, Shell shall have the right
to reduce the total number of FTEs assigned by Codexis to perform Codexis’ obligations under the Program by up to twelve (12) FTEs upon sixty (60) days’ advance written notice. 
 (ii) After the fourth (4th) anniversary of the Effective Date, Shell shall have the right to reduce the total
number of FTEs assigned by Codexis to perform Codexis’ obligations under the Program in accordance with the advance written notice and other requirements set forth in this Section 2.6(c)(ii). Any such advance written notice may be
delivered by Shell to Codexis only on or after November 2, 2010 and the number of FTEs that may be reduced will not be greater than as set forth in, and implemented after written notice thereof in accordance with, the table in this
Section 2.6(c)(ii), below. Notwithstanding anything to the contrary in this Section 2.6(c)(ii), no reductions may be noticed during the applicable standstill period as set forth in the table in this Section 2.6(c)(ii), below,
immediately after a FTE reduction already noticed (each such period during which no subsequent notice may be given, a “Standstill Period”). 
  
 [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has
been requested with respect to the omitted portions. 
  

 2 

					
	 Number of FTEs that May Be Reduced
	  	Standstill Period	 	Advance Notice Required
	[*]	  	[*]	 	[*]
	[*]	  	[*]	 	[*]
	[*]	  	[*]	 	[*]
	[*]	  	[*]	 	[*]

 By way of example, if
Shell elects to reduce the number of FTEs by [*] FTEs or less, no additional reductions may be made by Shell during the [*] day Standstill Period beginning on the date that Shell delivers advance written notice of such reduction
election. Similarly, if Shell elects to reduce the number of FTEs by more than [*] FTEs but less than or equal to [*], no additional reductions may be made by Shell during the [*] day Standstill Period beginning on the date that
Shell delivers advance written notice of such reduction election. 
  

	3.	ARTICLE 11, TERM AND TERMINATION, shall be amended as follows: 

 (a) Section 11.2 is hereby deleted and replaced in its entirety by the following: 
 11.2 Termination for Convenience. 
 (a) At any time after the fourth
(4th) anniversary of the Effective Date, Shell, in its sole discretion, may terminate this Amended and Restated Research Agreement, such termination to be effective after nine (9) months’ advance written notice to Codexis;
provided, however, that any such advance written notice may be delivered by Shell to Codexis only on or after November 2, 2010. By way of example, if notice of termination is delivered on November 2, 2010, then termination
would be effective as of August 2, 2011. Notwithstanding the previous sentence, in the event that, pursuant to Section 2.6(b)(iv), the number of FTEs was increased to greater than [*], Shell, at any time after the fourth
(4th) anniversary of the Effective Date, in its sole discretion, may terminate this Amended and Restated Research Agreement, such termination to be effective after twelve (12) months’ advance written notice to Codexis;
provided, however, that any such advance written notice may be delivered by Shell to Codexis only on or after November 2, 2010. By way of example, if notice of termination is delivered on November 2, 2010, then termination
would be effective as of November 2, 2011. 
 (b) If at any time after the fourth
(4th) anniversary of the Effective Date, Shell determines, in accordance with Section 2.6(c), to decrease the number of FTEs assigned by Codexis to perform Codexis’ obligations under the Program to less than [*], Codexis shall
have the right, but not the obligation, to terminate this Amended and Restated Research Agreement upon ninety (90) days’ advance written notice to Shell; provided, however, that in the event that (i) each such FTE
reduction by Shell occurs after successful achievement of the applicable Milestone for each Research Plan and (ii) Shell (or a Shell Affiliate or sublicensee) is actively developing the Program Technology for commercial application, then
Codexis shall have no right to terminate this Amended and Restated Research Agreement pursuant to this Section 11.2(b). 
  
 [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has
been requested with respect to the omitted portions. 
  

 3 

	4.	OTHER PROVISIONS. 

 All
provisions of the Research Agreement not expressly modified by this Second Amendment shall remain in full force and effect. 
 [Signature Page Follows] 
  
 [*] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 
  

 4 

 IN WITNESS WHEREOF, the
Parties have caused this Second Amendment to be executed by their respective duly authorized officers on the dates identified below but this Second Amendment shall become effective as of the Second Amendment Date, each copy of which will for all
purposes be deemed to be an original. 
  

									
	EQUILON ENTERPRISES LLC	 		 	CODEXIS, INC.
	DBA SHELL OIL PRODUCTS US	 		 		 	
					
	By:	 	 /s/ Tom N. Smith
	 		 	By:	 	 /s/ Joseph Sarret

	Name:	 	 Tom N. Smith
	 		 	Name:	 	 Joseph Sarret

	Title:	 	 President
	 		 	Title:	 	 Chief Business Officer

	Date:	 	 2/23/10
	 		 	Date:	 	 2/23/10

 Signature Page to Amendment No. 2 to the 
 Amended and
Restated Collaborative Research Agreement 
  
 [*] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}]]